Phio Pharmaceuticals Corp.(NASDAQ : PHIO)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Biotechnology
|VRTX||Vertex Pharmaceuticals, Inc.||1.03%||291.00||1.9%||$424.20m|
|GILD||Gilead Sciences, Inc.||-0.36%||60.87||1.0%||$370.94m|
|REGN||Regeneron Pharmaceuticals, Inc.||1.02%||619.89||2.6%||$347.97m|
|SNSS||Sunesis Pharmaceuticals, Inc.||4.65%||4.05||0.7%||$283.11m|
|GOVX||GeoVax Labs, Inc.||-4.13%||3.09||0.0%||$153.94m|
|CRSP||CRISPR Therapeutics AG||0.39%||81.72||0.6%||$133.29m|
|RYTM||Rhythm Pharmaceuticals, Inc.||11.81%||22.63||0.0%||$102.07m|
|MRTX||Mirati Therapeutics, Inc.||7.34%||92.91||1.6%||$100.38m|
|BMRN||BioMarin Pharmaceutical, Inc.||1.04%||96.82||4.2%||$96.33m|
Phio Pharmaceuticals Corp. is a biotechnology company engaged in the development of immuno-oncology therapeutics that addresses unmet medical needs. Its clinical product candidate includes RXI-109, an RNAi compound developed for the reduction of dermal scarring in planned surgeries. The company was founded on September 8, 2011 and is headquartered in Marlborough, MA.